Elena
Perez Ceballos
Asociado Ciencias de la Salud
![Foto de Elena](/img/uploaded/1a877ce161456762d7c5ac5f7e8268d0.jpeg)
![Foto de Hospital Clinico Universitario de Valencia](/img/noimage_org.png)
Hospital Clinico Universitario de Valencia
Valencia, EspañaHospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2022
-
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392
2017
-
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma
Cancer Medicine, Vol. 6, Núm. 11, pp. 2507-2514
2016
-
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy
British Journal of Haematology, Vol. 174, Núm. 6, pp. 859-867